Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma.
Albertsson-Lindblad A, Kolstad A, Laurell A, Räty R, Grønbæk K, Sundberg J, Pedersen LB, Ralfkiær E, Karjalainen-Lindsberg ML, Sundström C, Ehinger M, Geisler C, Jerkeman M. Albertsson-Lindblad A, et al. Blood. 2016 Oct 6;128(14):1814-1820. doi: 10.1182/blood-2016-03-704023. Epub 2016 Jun 27. Blood. 2016. PMID: 27354719 Free article. Clinical Trial.
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study.
Abrahamsson A, Albertsson-Lindblad A, Brown PN, Baumgartner-Wennerholm S, Pedersen LM, D'Amore F, Nilsson-Ehle H, Jensen P, Pedersen M, Geisler CH, Jerkeman M. Abrahamsson A, et al. Among authors: albertsson lindblad a. Blood. 2014 Aug 21;124(8):1288-95. doi: 10.1182/blood-2014-03-559930. Epub 2014 May 23. Blood. 2014. PMID: 24859361 Free article. Clinical Trial.
Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma.
Eskelund CW, Albertsson-Lindblad A, Kolstad A, Laurell A, Räty R, Pedersen LB, Geisler CH, Jerkeman M, Grønbæk K. Eskelund CW, et al. Among authors: albertsson lindblad a. Haematologica. 2018 Nov;103(11):e541-e543. doi: 10.3324/haematol.2018.194399. Epub 2018 May 24. Haematologica. 2018. PMID: 29794145 Free PMC article. Clinical Trial. No abstract available.
Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA-BERIT) experience.
Lindberg Å, Eskelund CW, Albertsson-Lindblad A, Kolstad A, Laurell A, Räty R, Grønbaek K, Geisler CH, Jerkeman M. Lindberg Å, et al. Among authors: albertsson lindblad a. Hematol Oncol. 2022 Feb;40(1):22-30. doi: 10.1002/hon.2940. Epub 2021 Nov 10. Hematol Oncol. 2022. PMID: 34713465 Clinical Trial.
Secondary malignancies among mantle cell lymphoma patients.
Abalo KD, Smedby KE, Ekberg S, Eloranta S, Pahnke S, Albertsson-Lindblad A, Jerkeman M, Glimelius I. Abalo KD, et al. Among authors: albertsson lindblad a. Eur J Cancer. 2023 Dec;195:113403. doi: 10.1016/j.ejca.2023.113403. Epub 2023 Oct 29. Eur J Cancer. 2023. PMID: 37952281 Free article.